Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with WeightWatchers to ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing ...

The announcement expands telehealth firms’ portfolio of branded glp-1 drugs to offer at a time when the Food and Drug Administration (FDA) is prohibiting them from selling and making compounded ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Eli Lilly Wednesday filed lawsuits against four telehealth ... Lilly alleged the companies are mass-marketing slightly different versions of Lilly drugs to get around Food and Drug Administration ...

In 2022, anti-abortion groups sued to challenge a decision by the Food and Drug Administration allowing the drug to be prescribed via telehealth and sent by mail.

The Trump administration on Monday asked a judge to toss out a lawsuit from three GOP-led states seeking to cut off telehealth access to abortion medication mifepristone.

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to customers. ... However, the US Food and Drug Administration ...